Regent Pacific Group Ltd (fra:RPG) Share Price

Company Profile

Business description
Regent Pacific Group Ltd is an investment holding company that runs through two segments: Biopharma and Corporate Investment. Its Biopharma segment is engaged in the research, development, manufacturing, marketing, and sales of pharmaceutical products, and it also develops artificial intelligence (AI) systems for the field of biological aging clocks. The Corporate Investment segment is engaged in the investment in listed and unlisted corporate entities. The majority of its revenue comes from the Biopharma segment. Geographically, the Europe; U.S.; and Asia Pacific. It derives maximum revenue from Europe.
Contact
5 Queen's Road Central
8th Floor, Henley Building
Hong Kong
HKG
T: +852 25146111
https://www.endurancerp.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
16

Recommended

Regulatory pressures squeeze growth outlook for wide moat ASX share.

Roy Van Keulen | 08 July 2026

How the proposed CGT floor creates unexpected outcomes across different incomes.

Tony Dillon | 07 July 2026

Is the market overlooking this undervalued fast food chain?

Johannes Faul, CFA | 07 July 2026

Index	Last price	Change	% Change
All Ordinaries	8,899.90	40.70	-0.46%
CAC 40	8,436.24	43.63	-0.51%
DAX 40	25,465.25	352.64	-1.37%
Dow JONES (US)	52,925.15	130.76	-0.25%
FTSE 100	10,665.88	14.11	0.13%
HKSE	23,855.75	358.86	1.53%
NASDAQ	25,818.69	302.47	-1.16%
Nikkei 225	67,882.84	374.12	-0.55%
NZX 50 Index	13,662.86	99.93	-0.73%
S&P 500	7,503.85	33.58	-0.45%
S&P/ASX 200	8,701.80	35.80	-0.41%
SSE Composite Index	3,993.88	3.64	0.09%